Duquesne Family Office LLC
Institutional investor · Portfolio as of Q4 2018
Top Holdings31 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
MICROSOFT CORP | 4.6M | $469.1M | 27.2% | $93.93 | 0.00% | 1 qtr | New 98 |
AMAZON.COM INC | 98,428 | $147.8M | 8.6% | $73.90 | 0.00% | 1 qtr | New 94 |
SALESFORCE.COM INC | 1.1M | $146.9M | 8.5% | $133.06 | 0.00% | 1 qtr | New 94 |
TESLA INC | 299,800 | $99.8M | 5.8% | — | — | — | New — |
ABBOTT LABORATORIES | 1.3M | $93.7M | 5.4% | $62.58 | 0.00% | 1 qtr | New 93 |
WORKDAY INC-CLASS A | 525,400 | $83.9M | 4.9% | $159.56 | 0.00% | 1 qtr | New 83 |
COUPA SOFTWARE INC | 1.1M | $71.1M | 4.1% | — | — | 1 qtr | New 83 |
ADOBE INC | 301,015 | $68.1M | 3.9% | $223.13 | 0.00% | 1 qtr | New 83 |
ISHARES MSCI EMERGING MARKETS INDEX FUND | 1.7M | $65.6M | 3.8% | $33.39 | 0.00% | 1 qtr | New 83 |
GILEAD SCIENCES INC | 1M | $64M | 3.7% | $47.26 | +193.95% | 1 qtr | New 83 |
INTUITIVE SURGICAL INC | 110,300 | $52.8M | 3.1% | $157.07 | 0.00% | 1 qtr | New 82 |
ILLUMINA INC | 139,500 | $41.8M | 2.4% | $290.11 | 0.00% | 1 qtr | New 76 |
PAYPAL HOLDINGS INC | 408,535 | $34.4M | 2.0% | $83.07 | 0.00% | 1 qtr | New 67 |
MEDTRONIC PLC | 372,500 | $33.9M | 2.0% | $74.08 | +22.30% | 1 qtr | New 67 |
ISHARES BIOTECHNOLOGY ETF | 350,300 | $33.8M | 2.0% | $93.02 | 0.00% | 1 qtr | New 67 |
DELTA AIR LINES INC | 626,600 | $31.3M | 1.8% | $47.20 | 0.00% | 1 qtr | New 67 |
ALIBABA GROUP HOLDING-SP ADR | 174,400 | $23.9M | 1.4% | $132.09 | 0.00% | 1 qtr | New 66 |
AC IMMUNE SA | 2.5M | $23.5M | 1.4% | $9.78 | 0.00% | 1 qtr | New 66 |
MERCADOLIBRE INC | 74,016 | $21.7M | 1.3% | $292.09 | 0.00% | 1 qtr | New 66 |
NETFLIX INC | 66,010 | $17.7M | 1.0% | $25.61 | 0.00% | 1 qtr | New 66 |
Duquesne Family Office LLC manages $1.7B across 31 positions as of Q4 2018. Top holdings: MSFT (27.2%), AMZN (8.6%), CRM (8.5%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1.5/5.0.
Active quarter - 30 new positions, 0 exits, 0 increased. Top move: MSFT (NEW, conviction 98). Portfolio: $1.7B across 31 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer